microbiometimes.com | Home - Microbiome Times

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow:

Meta Tags

Title	Home - Microbiome Times
Description	FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for Sign up to our Free Newsletter Contact Us Search for: Human Health Finance Drug Database Login About Issue Archive Advertise Recruitment Marketing Pharma
Keywords	N/A

Server Information

WebSite	microbiometimes.com
Host IP	104.21.60.42
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

microbiometimes.com Valuation

US$2,407,711

Last updated: 2023-05-01 10:22:08

microbiometimes.com has Semrush global rank of 4,396,004. microbiometimes.com has an estimated worth of US$ 2,407,711, based on its estimated Ads revenue. microbiometimes.com receives approximately 277,813 unique visitors each day. Its web server is located in United States, with IP address 104.21.60.42. According to SiteAdvisor, microbiometimes.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,407,711
Daily Ads Revenue	US$2,223
Monthly Ads Revenue	US$66,676
Yearly Ads Revenue	US$800,101
Daily Unique Visitors	18,521
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
microbiometimes.com.	A	298	IP: 104.21.60.42
microbiometimes.com.	A	298	IP: 172.67.191.116
microbiometimes.com.	AAAA	298	IPV6: 2606:4700:3033::6815:3c2a
microbiometimes.com.	AAAA	298	IPV6: 2606:4700:3031::ac43:bf74
microbiometimes.com.	NS	86400	NS Record: will.ns.cloudflare.com.
microbiometimes.com.	NS	86400	NS Record: beth.ns.cloudflare.com.
microbiometimes.com.	MX	300	MX Record: 50 mx3.zoho.com.
microbiometimes.com.	MX	300	MX Record: 20 mx2.zoho.com.
microbiometimes.com.	MX	300	MX Record: 10 mx.zoho.com.
microbiometimes.com.	TXT	300	TXT Record: zoho-verification=zb15159378.zmverify.zoho.com
microbiometimes.com.	TXT	300	TXT Record: google-site-verification=egMq279iWz4nj9Ge4imcuPfdgc-OAivH_hVtbO3ptos
microbiometimes.com.	TXT	300	TXT Record: v=spf1 include:zoho.com ~all

HtmlToTextCheckTime:2023-05-01 10:22:08

Sign up to our Free Newsletter Contact Us Search for: Human Health Finance Drug Database Login About Issue Archive Advertise Recruitment Marketing Pharma & Human Health FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013 Finance Biomica Announces Closing of $20 Million Financing Round Editor’s Choice Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ Editor’s Choice Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies Finance DSM agrees terms to acquire postbiotics pioneer Adare Biome Editor’s Choice Editor’s Choice Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ April 27, 2023 Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science today announced the U.S. Food and Drug Administration (FDA) approval of VOWSTTM (fecal microbiota spores, live-brpk), formerly called SER-109, an orally administered microbiota-based therapeutic to prevent

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 01:17:20 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
x-powered-by: PHP/7.1.33
x-redirect-by: WordPress
location: https://microbiometimes.com/
vary: User-Agent
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=WUqBHoCcsaTrIOOmq2qYgY6bq3gZzPD3ZVk8q1y0c7c0ewkpmKtu1ZrInP2DnKB%2Bt8r7%2FBQokkiMlsJ%2Fk2LoinVfzkOt9On4v1iHVHJ4MotneDy7ocYNE%2F3Y2L3DkkdQNlPxMdUn"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a2f5d5f19832aa8-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Sun, 24 Oct 2021 01:17:22 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.1.33
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-tec-api-version: v1
x-tec-api-root: https://www.microbiometimes.com/wp-json/tribe/events/v1/
x-tec-api-origin: https://www.microbiometimes.com
vary: User-Agent
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Pu5QdD%2FaQel6FndviKiAOhlCl4LSTXERnWybCpVyrV2MCOvuJNee6WjvE5cSCw9vZtGg5gYG6eRCPQZJ3v70tcI0eWAxm%2Fp5gpg5qleW0JhANM4x2%2FAfBM1N2lMdpXimUfdq4JiM"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a2f5d69ca39e222-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

microbiometimes.com Whois Information

Domain Name: MICROBIOMETIMES.COM
Registry Domain ID: 2212477620_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-01-19T13:14:36Z
Creation Date: 2018-01-13T18:09:04Z
Registry Expiry Date: 2026-01-13T18:09:04Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: BETH.NS.CLOUDFLARE.COM
Name Server: WILL.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T10:10:17Z <<<

microbiometimes.com valuation and analysis